Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Alpha-methyldopa interference with the phosphotungstate uric acid test.

R E Small, H R Freedy, B J Small

    American Journal of Hospital Pharmacy
    |June 11, 1976
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Medical care disruptions during the first six months of the COVID-19 pandemic: the experience of older breast cancer survivors.

    Breast cancer research and treatment·2021
    Same author

    Medical Care Disruptions During the First Six-Months of the COVID19 Pandemic: The Experience of Older Breast Cancer Survivors.

    Research square·2021
    Same author

    Impact of Dietary Factors and Inflammation on Cognition among Older Adults.

    The journal of prevention of Alzheimer's disease·2017
    Same author

    Fecal incontinence as a moderator between dietary intake and depressive symptoms among a sample of older adults obtained from the National Health and Nutrition Examination Survey (NHANES).

    Aging & mental health·2017
    Same author

    A systematic review and meta-analysis of changes in cognitive functioning in adults undergoing hematopoietic cell transplantation.

    Bone marrow transplantation·2013
    Same author

    A high-fat/high-cholesterol diet inhibits growth of fetal hippocampal transplants via increased inflammation.

    Cell transplantation·2011
    Same journal

    National health care reform, Part 2: Response to pharmacists.

    American journal of hospital pharmacy·1994
    Same journal

    Validity of originality assessment.

    American journal of hospital pharmacy·1994
    Same journal

    Unit dose dispensing of chromic phosphate P 32 suspension.

    American journal of hospital pharmacy·1994
    Same journal

    Hydralazine injection still available.

    American journal of hospital pharmacy·1994
    Same journal

    Improved extemporaneous formulation of cyclosporine ophthalmic drops.

    American journal of hospital pharmacy·1994
    Same journal

    Paclitaxel diluent and the case of the slippery spike.

    American journal of hospital pharmacy·1994
    See all related articles

    Alpha-methyldopa does not interfere with the phosphotungstate method for analyzing uric acid levels. This study found no significant differences in uric acid measurements between patients taking alpha-methyldopa and controls.

    Area of Science:

    • Clinical Chemistry
    • Pharmacology
    • Nephrology

    Background:

    • Hypertension management often involves medications that may affect laboratory test results.
    • Alpha-methyldopa is a commonly prescribed antihypertensive agent.
    • The phosphotungstate method is a standard assay for determining uric acid levels.

    Purpose of the Study:

    • To evaluate the potential interference of alpha-methyldopa with the phosphotungstate method for uric acid analysis.
    • To determine if therapeutic levels of alpha-methyldopa affect uric acid measurements.

    Main Methods:

    • Comparative analysis of uric acid levels in hypertensive patients treated with alpha-methyldopa versus normotensive controls.
    • In vitro studies using serum with varying concentrations of alpha-methyldopa.

    Related Experiment Videos

  • Uric acid quantification via both phosphotungstate and uricase methods.

    • Main Results:

    • No significant difference in uric acid values between the alpha-methyldopa treatment group and the control group using the phosphotungstate method.
    • In vitro studies indicated that a concentration of 60 mug/ml of alpha-methyldopa was required to cause clinically significant interference.
    • The mean plasma alpha-methyldopa concentration in patients was 2.03 mug/ml, well below the interference threshold.

    Conclusions:

    • Therapeutic levels of alpha-methyldopa do not interfere with the accuracy of the phosphotungstate method for uric acid analysis.
    • The phosphotungstate method is a reliable assay for uric acid determination in patients treated with alpha-methyldopa.